Stay current with the latest news on Blood Cancer United research programs, FDA approvals, research grants and awards, the Therapy Acceleration Program, Beat AML and other clinical research programs, and more.
News
LLS Applauds FDA Approval of New Treatment Option for Pediatric Patients with Hodgkin Lymphoma
The U.S. Food and Drug Administration (FDA) yesterday approved brentuximab vedotin (Adcetris®) in combination with standard dose-intensive chemotherap…
News
FDA Broadens Treatment Options for Relapsed/Refractory Multiple Myeloma
The Food and Drug Administration (FDA) has approved a new treatment, teclistamab (Tecvayli), for adults with multiple myeloma that has returned or con…
News
FDA Approves New Treatment for Children and Young Adults with Chronic Graft versus Host Disease
This week marked another milestone for the treatment of graft versus host disease in children. The U.S. Food and Drug Administration (FDA) approved ib…
Research
Yescarta® Receives U.S. FDA Approval as First CAR T-cell Therapy for Initial Treatment of Relapsed or Refractory Large B-cell Lymphoma (LBCL)
SANTA MONICA, Calif. April 1, 2022 - Kite, a Gilead Company (Nasdaq: GILD), today announced the U.S. Food and Drug Administration (FDA) has approved Y…
News
FDA Approves Immunotherapy for Aggressive Form of Follicular Lymphoma
The U.S. Food and Drug Administration (FDA) has approved CAR T-immunotherapy tisagenlecleucel (Kymriah®) for patients with follicular lymphoma (FL) wh…
News
FDA Approves Combination Therapy for Patients with Certain Forms of Acute Myeloid Leukemia
The Food and Drug Administration (FDA) recently approved a combination of the targeted therapy ivosidenib (Tibsovo) and the chemotherapy azacitidine f…
Declaración sobre la autorización de la FDA de la tercera vacuna contra la COVID-19 de Pfizer y Moderna para personas con sistemas inmunitarios debilitados
Como organización basada en la ciencia, la Sociedad de Lucha contra la Leucemia y el Linfoma (LLS, por sus siglas en inglés), celebra la reciente deci…
News
FDA Approves New Drug for Patients with Rare Blood Cancer (Myelofibrosis)
The Food and Drug Administration (FDA) recently approved a drug for the treatment of intermediate or high-risk primary or secondary myelofibrosis, the…
News
FDA Approves First Drug for The Prevention of Acute Graft Versus Host Disease
The Food and Drug Administration (FDA) recently approved abatacept (Orencia), in combination with certain immunosuppressants, for the prevention of ac…
News
FDA Approves New Treatment Option for Patients with Multiple Myeloma at First or Subsequent Relapse
The U.S. Food and Drug Administration (FDA) recently granted the seventh approval to daratumumab for the treatment of multiple myeloma. This injectabl…
News
FDA Approves the First Interferon for Adults With Polycythemia Vera
This is the first medication approved for PV that patients can take regardless of their treatment history, meaning it can be used to treat this rare f…
